Manufacture of basic pharmaceutical products
SCANDIDERMA AS
Revenue 2024
NOK 1.3m
Operating profit
NOK 1.1m
Equity
NOK −6.0m
Incorporated
2010
Share capital
NOK 241,000
Roles
Daglig lederGeir Håvard Kvalheim
Styrets lederGeir Håvard Kvalheim
StyremedlemEdel Margrete Kandal
StyremedlemKai-Hugo Hebnes
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| GHK INVEST AS | 35.2% | 85000.000000 | 2025 |
| KANDAL INVEST AS | 19.2% | 46231.000000 | 2025 |
| SEEBERG HOLDING AS | 14.2% | 34125.000000 | 2025 |
| IMPETO AS | 6.0% | 14492.000000 | 2025 |
| MONTECRISTO INV. INTERNATIONAL | 5.0% | 12050.000000 | 2025 |
| INGMAR FIMREITE | 4.1% | 10000.000000 | 2025 |
| JACEK BARTOSIK | 4.1% | 10000.000000 | 2025 |
| DRUG DISCOVERY LABORATORY AS | 2.1% | 5000.000000 | 2025 |
| LAVOLD INVEST AS | 2.1% | 5000.000000 | 2025 |
| R3 HOLDING AS | 2.1% | 5000.000000 | 2025 |
| ARILD RUNE KLAKEGG | 1.9% | 4500.000000 | 2025 |
| FIMREITE AS | 1.2% | 2898.000000 | 2025 |
| REMI LUNDE SOLBAKKEN | 0.9% | 2173.000000 | 2025 |
| ARTHUR ANDERSEN KNUTSEN | 0.6% | 1449.000000 | 2025 |
| BÅRD STIAN NYBØ | 0.6% | 1449.000000 | 2025 |
| DANIEL ERIKSEN MARTINSEN | 0.3% | 641.000000 | 2025 |
| CHRISTOFFER RYAN | 0.3% | 641.000000 | 2025 |
| KLAKEGG HOLDING AS | 0.2% | 500.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.